Home
>
National Drug Code (NDC)
>
Angeliq
Angeliq - 50419-482-72 - (drospirenone and estradiol)
Drug Information of Angeliq
| Product NDC: | 50419-482 |
| Proprietary Name: | Angeliq |
| Non Proprietary Name: | drospirenone and estradiol |
| Active Ingredient(s): | .25; .5 mg/1; mg/1 & nbsp; drospirenone and estradiol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Angeliq
| Product NDC: | 50419-482 |
| Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021355 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120229 |
Package Information of Angeliq
| Package NDC: | 50419-482-72 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (50419-482-72) > 14 TABLET, FILM COATED in 1 BLISTER PACK (50419-482-71) |
NDC Information of Angeliq
| NDC Code | 50419-482-72 |
| Proprietary Name | Angeliq |
| Package Description | 1 BLISTER PACK in 1 CARTON (50419-482-72) > 14 TABLET, FILM COATED in 1 BLISTER PACK (50419-482-71) |
| Product NDC | 50419-482 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | drospirenone and estradiol |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120229 |
| Marketing Category Name | NDA |
| Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
| Substance Name | DROSPIRENONE; ESTRADIOL |
| Strength Number | .25; .5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |
